The Impact of BCR-ABL Tyrosine Kinase Inhibitor Therapy on Renal Function in Patients at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A 2023 Cross-Sectional Study
No Thumbnail Available
Date
2024-03-03
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Addis Ababa University
Abstract
BCR-ABL tyrosine kinase inhibitors are effective in treating various cancers, but concerns
exist regarding their potential to cause kidney damage. This study investigated the association between
tyrosine kinase inhibitors and renal toxicities in patients at Tikur Anbesa Specialized Hospital, Addis
Ababa, Ethiopia.
Description
Keywords
therapy on renal function in patients